Search for: "Janssen Pharmaceutica"
Results 61 - 80
of 97
Sorted by Relevance
|
Sort by Date
21 Jan 2015, 9:40 am
Janssen Pharmaceutica, Inc., 288 F. [read post]
27 Oct 2021, 5:15 am
Janssen Pharmaceutica, N.V., No. 21-202 (NHK-Fintiv rule for denying petitions; appealability of IPR petition denial); Apple Inc. v. [read post]
11 Jan 2011, 11:07 pm
Senators follow House colleagues in making BPCIA exclusivity clarifications; New study suggests benefits of longer drug exclusivity period (FDA Law Blog) US: BPCIA’s principal authors seek to clarify Congressional intent with respect to 12-year exclusivity period; PhRMA/BIO request ‘umbrella exclusivity’ (FDA Law Blog) US: BIO’s IP priorities for 2011 (PatentlyBIOtech) US: BIO survey shows support for DNA-based patents despite some reservations (Patent Docs) US:… [read post]
13 Aug 2008, 5:00 am
Janssen Pharmaceutica, Inc., No. 07-12259, slip op. (11th Cir. [read post]
24 Jan 2012, 6:34 pm
Cir. 2008) and Janssen Pharmaceutica, N.V. v. [read post]
21 Jun 2018, 10:33 am
It was first developed by Janssen Pharmaceutica around 1960 and approved for American medical use in 1968 as an injectable anesthetic called Sublimaze. [read post]
14 Dec 2021, 9:57 am
Janssen Pharmaceutica, N.V., No. 21-202. [read post]
6 Aug 2009, 6:50 am
Janssen Pharmaceutica, Inc., 288 Fed. [read post]
14 Aug 2009, 1:04 am
Janssen Pharmaceutica, Inc., 288 Fed. [read post]
14 Aug 2009, 1:04 am
Janssen Pharmaceutica, Inc., 288 Fed. [read post]
14 Aug 2009, 1:04 am
Janssen Pharmaceutica, Inc., 288 Fed. [read post]
1 Dec 2015, 11:50 am
Xarelto was developed by German pharmaceutical giant Bayer, and is jointly marketed in the United States with Janssen Pharmaceuticals, a division of Johnson & Johnson. [read post]
17 Feb 2010, 5:10 am
(Patent Docs) Razadyne (Galantamine) / Strattera (Atomoxetine) – US: Walking the enablement/non-obviousness tightrope: Janssen Pharmaceutica N.V. v. [read post]
29 Apr 2011, 7:43 am
Janssen Pharmaceutica Inc. [read post]
27 Mar 2009, 8:00 am
; no skulduggery involved in pharma enquiry submission switch says EPO (IPKat) (IAM) India: Public sector IP and socially responsible licensing (Spicy IP) India: Pharma lobby wants a probe into delayed orders (Spicy IP) UK: Euro costs in UK litigation: Actavis UK Ltd v Novartis AG (PatLit) US: Two biosimilars bills introduced in the House: HR 1427, the Promoting Innovation and Access to Life Saving Medicine Act; and H.R. 1548, the Pathway to BioSimilars Act (California Biotech Law Blog) (Managing… [read post]
28 Jul 2009, 3:54 am
Janssen Pharmaceutica, Inc., 288 Fed. [read post]
20 Sep 2021, 3:31 pm
Janssen Pharmaceutica (appealing institution denials); Apple Inc. v. [read post]
17 May 2021, 4:17 am
Janssen Pharmaceutica NV & Another 1998 BIP 264. [read post]
7 Mar 2008, 5:47 am
Risperidone is an antipsychotic medication sold by Janssen Pharmaceutica (a subsidiary of Johnson & Johnson) under the trade-name Risperdal ®. [read post]
10 Jul 2007, 12:49 am
., has awarded $5.5 million to the estate of a young man who died from an overdose due to the malfunction of a popular prescription pain patch manufactured by two Johnson & Johnson subsidiaries -- Alza Corp. and Janssen Pharmaceutica. [read post]
